We summarize data on the potential interaction of trans isomeric fatty acids [trans fatty acids (TFAs)] with the availability of longchain polyunsaturated fatty acids (LC-PUFAs) in the perinatal period. Today, TFA intakes in pregnant and lactating women can be estimated to be w1% of energy in the majority of the population. The significant inverse associations seen between TFAs and LC-PUFAs in pregnant women in 3 different European populations investigated in a recent study raise doubts about the nutritional adequacy of high TFA intakes during pregnancy. In a recent study on the TFA content of human milk in a sizable group of mothers at the sixth week of lactation, both arachidonic and docosahexaenoic acids correlated significantly inversely to 18-carbon TFAs but not to 16-carbon TFAs, and at the sixth month of lactation arachidonic acid correlated significantly inversely to 18-carbon TFAs but not to 16-carbon TFAs. Similarly, significant inverse correlations were seen between 18-carbon TFAs and arachidonic and docosahexaenoic acids in both artery and vein wall lipids in a sizable group of healthy term infants. The TFA data obtained in umbilical blood vessel wall lipids were related to the neurologic condition of healthy children at 18 mo of age: children with minimal neurologic dysfunction at age 18 mo had significantly higher cord blood vein wall trans octadecadienoic acid values than did neurologically normal children. Total TFA values as well as total 18-carbon TFA values in umbilical vein wall lipids were significantly inversely associated with neurologic optimality score. Contradictory data renders it impossible to draw firm conclusions on the role of TFAs in modifying fetal growth; however, TFA exposure may be a confounding parameter in studies that investigate the relation between fetal fatty acid supply and intrauterine growth.
INTRODUCTION
Double bonds in unsaturated fatty acids may either be cis configured, in that the vicinal parts of the carbon chain point to the same side of the double bond, or they may be trans configured with the carbon chain attached to the double bond from the opposite direction. The physicochemical characteristics of trans isomeric fatty acids [trans fatty acids (TFAs)] 5 differ considerably from those of the cis configured isomers (1) . The most important difference is the considerably higher melting point of trans as compared with cis isomers: at room temperature, most dietary cis unsaturated fatty acids are fluid, whereas their respective trans isomers are solid. The inclusion of TFAs into various dietary products offers some practical advantages both for the manufacturer and the consumer.
However, TFAs have been attributed untoward health effects. The substitution of 2% total energy intake from carbohydrates with TFAs was associated with a significant increase in the incidence of coronary heart disease in a meta-analysis of 4 observational studies (2) . In turn, the substitution of 2% of total energy intake from TFAs with cis PUFAs or even with saturated fatty acids was estimated to decrease coronary heart disease risk significantly, by 24 to 17% (3) . The potential health risk associated with TFA intake led to slightly differently formulated, but unanimously restrictive, dietary advice from the American Dietetic Association, American Heart Association, Institute of Medicine, National Cholesterol Education Program Adult Treatment Panel III, and US Dietary Guidelines on TFA intakes (summarized in tabulated form in reference 4). As an effect of the public concern about the potential health hazards of TFAs, TFA intakes decreased spectacularly in many industrialized countries (5, 6) . However, TFA consumption may be increasing in some developing economies (7) .
From the perinatal perspective, it is not the atherogenic effect of TFAs but the potential interference of TFAs with the availability of long-chain PUFAs (LC-PUFAs) that deserves special attention. In blood lipids of both women at different stages of pregnancy (8, 9) and their offspring at birth (10) (11) (12) as well as in human milk (HM) (13) (14) (15) , inverse associations were reported between TFAs and various LC-PUFAs. Because LC-PUFAs are important for neurodevelopment in infancy (16) (17) (18) (19) , the potentially untoward effect of TFA exposure also has been receiving increased attention within the pediatric community for w15 y (20) .
In the present article we summarize data on the interaction of TFAs with the availability of LC-PUFAs in the perinatal period as well as data on potential functional consequences of perinatal TFA intake. Although dietary influences on mother, fetus, and infant are obviously interrelated, for the clarity of presentation we discuss separately the effect of TFA exposure on pregnant and lactating women, on the fetus, and on the growing infant and child. We focus on information published during the past few years and include animal data only if they are essential for the interpretation of human observations.
TFA EXPOSURE IN PREGNANT AND LACTATING WOMEN
Maternal TFA exposure can be estimated directly by investigating dietary intake or indirectly by determining fatty acid composition of maternal samples, including HM.
Dietary TFA intake in pregnant and lactating women It can be assumed that TFA intake in women of childbearing age is similar to the intake characteristic of the general population. Mean TFA intakes in 14 European countries participating in the Trans Fatty Acids in Foods in Europe study were w1.1% of energy (with upper and lower limits of 2.0% and 0.5% of energy in Iceland and in Italy, respectively) (21) . In a further study carried out in the Asian part of Turkey (22) , TFA intakes in lactating women proved to be 1.12% of energy, whereas in women aged 19-49 y and living in India the corresponding value was 0.6% of energy (23) . In some studies TFA intakes were reported in absolute amounts consumed. In a small group of Australian pregnant women, mean TFA intakes were found to be 3.7 g/d in the middle of the 1990s, whereas in the United States the mean TFA intake in a large (n . 100) group of pregnant women investigated from 1999 to 2002 was found to be 2.35 g/d (24) .
In Finland, dietary TFA intakes were estimated with the same methodology in sizable (n . 500) groups of women investigated in 1982, 1992, 2002 , and 2007 and were found to continuously decrease, with mean values of 1.5%, 0.7%, 0.5%, and 0.4% of energy, respectively (6) . Although it is unlikely that the .70% reduction seen in Finland in TFA intakes within 25 y might be regarded as characteristic of many other countries, current TFA intakes in the general population including in pregnant and lactating women can be estimated to be approximately or ,1% of energy in most cases.
Contribution of TFAs to fatty acid composition of blood lipids in pregnant women
There are at least 6 studies that reported TFA values in blood lipids in pregnant women who were investigated before delivery (8, 9, (25) (26) (27) (28) . (Here we do not discuss several other studies addressing the question of maternal blood obtained at delivery, because we believe that many hormonal variables may considerably influence the fatty acid composition of blood lipids investigated close to delivery.) Individual TFA values were reported only in a few studies. The contribution of trans octadecenoic acid (18:1n-9t) to plasma phospholipids was found to be 0.23% in Dutch women investigated at around the 12th week of gestation (27) . In another study in The Netherlands, median values for plasma phospholipid trans octadecenoic acid were found to be 0.45% at the 16th, 0.44% at the 22nd, and 0.42% at the 32nd week of gestation (28) . In Spanish women investigated at the 26th to 27th week of gestation, the contribution of trans octadecenoic acid to total plasma lipids was reported to be 0.28% (25) .
Total TFA values were measured in plasma phospholipids and cholesteryl esters in pregnant Belgian women at the 12th, 22nd, and 32nd week of gestation (26) . In phospholipids, mean total TFA values were 0.59%, 0.59%, and 0.60% in the first, second, and third trimesters of pregnancy, whereas the corresponding values in cholesteryl esters were 0.43%, 0.47%, and 0.49% (26) . Considerably higher mean total TFA values were reported for pregnant Canadian women at the 35th week of gestation, as follows: 2.37% in phospholipids, 1.57% in cholesteryl esters, and 3.99% in triacylglycerols (8) .
We recently compared the contribution of TFAs to erythrocyte membrane phosphatidylcholine and phosphatidylethanolamine lipids at the 20th week of gestation in pregnant Spanish (n = 120), German (n = 78), and Hungarian (n = 43) women entering into an n-3 LC-PUFA supplementation trial (9) . The sum of TFAs did not differ between the 3 groups in phosphatidylcholine lipids ( Figure 1 ). However, in phosphatidylethanolamine lipids, total TFA values were significantly lower in Hungarian than in German or Spanish women ( Figure 1 ). An interesting finding of this study was the demonstration of significant inverse correlations between TFAs and the principal LC-PUFAs arachidonic acid (AA; 20:4n-6) and DHA (22:6n-3) in relatively large groups of Table 1) . With the exception of correlation between total TFAs and DHA in phosphatidylethanolamine lipids in Hungarian women, uniformly significant inverse correlations were seen between total TFAs and both AA and DHA values ( Table 1) . The significant inverse associations seen between TFAs and LC-PUFAs in pregnant women in 3 different European populations (9) support the concept of the modifying effect of TFAs on LC-PUFA status. One potential mechanism may be the disturbing effect of TFAs on the conversion of essential fatty acids to their longer-chain metabolites. Experimental data obtained in rodent tissues (29) as well as in human fibroblast cultures (30) indicate that TFAs inhibit the desaturation and chain-elongation of linoleic (18:2n-6) and a-linolenic (18:3n-3) acids to their respective LC-PUFA metabolites. Another potential mechanism may be the disturbing influence of TFAs on the incorporation of LC-PUFAs into membrane structures (31, 32) , including erythrocyte membranes. Although the observational data summarized in Table 1 do not allow the conclusion that high dietary TFA exposure in pregnant women interferes with LC-PUFA metabolism, the results certainly call into question the nutritional adequacy of high TFA intakes during pregnancy.
Contribution of TFAs to the fatty acid composition of HM
The TFA content in HM has been long considered to be an important potential health hazard in infant nutrition (for review see reference 20). Despite considerable cumulative data on the topic, the changing, hopefully decreasing, dietary TFA exposure in lactating women initiated several recent studies as well. In the United States, mean TFA content in HM samples obtained between 1996 and 2002 was reported to be 7.0%, with considerable interindividual variability from 2.5% to 13.8% (33) . In Canada, where the mean TFA content in HM was as high as 7.1% in 1998 (13), significant decreases from 6.2% to 5. (34) . Similarly, the contribution of total TFAs to HM fatty acids was only 2.13% in Turkish mothers investigated at the 12th to 16th weeks of lactation (22) .
We recently investigated the TFA content of HM in a sizable group of German mothers donating milk samples both at the sixth week and sixth month of lactation (14, 15) . The contribution of trans octadecenoic acid was significantly higher at the sixth week (0.87%) than at the sixth month (0.60%) of lactation. Consequently, total TFA values were also significantly higher at the sixth week (1.55%) than at the sixth month (1.43%) of lactation. Even at these relatively low amounts of TFA, we found significant inverse correlations between TFA and LC-PUFA values ( Table 2) . At the sixth week of lactation, both AA and DHA correlated significantly and inversely to 18-carbon TFAs, but not to 16-carbon TFAs (Table 2) . However, by the sixth month of lactation (ie, by the time trans octadecenoic acid values significantly decreased in HM samples), the negative correlation between TFAs and DHA disappeared. The negative associations between 18-carbon but not 16-carbon TFAs and LC-PUFAs in the HM samples are in concert with our previous findings obtained in plasma lipids of healthy children aged 1-15 y (35) and venous cord blood lipids in healthy infants with an atopic trait (11) . The disappearance of the inverse association between TFAs and DHA by the sixth month of lactation can be explained by the significant decrease in TFAs between the sixth week and sixth month of lactation. It is important to note that even at relatively low original amounts of HM TFAs (w1.5%), further decreases in TFAs can probably be associated with reduction in the strength of the untoward association of TFAs with the availability of LC-PUFAs.
TFA EXPOSURE OF THE FETUS AND INFANT
Because TFAs are not synthesized in the maternal or in the fetal organism, TFA values detected in fetal tissues at birth can be regarded as indicators of maternal dietary TFA exposure. After the pioneer report of Koletzko and Müller (36) , which called attention to TFAs in cord plasma lipids, the relatively easily accessible cord blood lipids were used to investigate intrauterine TFA exposure of the fetus in several studies. However, the various cord lipid fractions investigated in the different studies make it difficult to directly compare data.
Median or mean values of total TFAs in cord blood plasma phospholipids, cholesteryl esters, and triacylglycerols were reported in comparable studies in Austrian (11), Canadian (8), and German (37) infants investigated in the latter part of the 1990s (Figure 2 ). Even this small-scale comparison indicates considerable variability in reported TFA values, even between infants living under apparently similar socioeconomic conditions, such as in Austria and Germany. This variability may reflect not only differences in dietary TFA intakes but methodologic differences in sample collection and analytic procedures as well. Consequently, caution is needed when interpreting cord blood plasma lipid data as indicators of dietary TFA intake. Comparing one lipid class only may be misleading: eg, despite the 3-fold difference in total TFAs in cholesteryl esters between Austrian and German infants, total TFA values in nonesterified fatty acids were practically identical (Austria: 1.59%; Germany: 1.58%).
Uncertainties in the interpretation of cord blood plasma lipid TFA values gave rise to the methodologically more demanding attempt to use cord blood vessel wall lipids to characterize TFA exposure in the fetus (12, 38) . The methodologic difficulties are partly related to the relatively small percentage contribution of individual TFAs to cord vessel wall lipids: eg, median trans octadecenoic acid values in 308 Dutch infants investigated in Groningen (12) and in 328 Dutch infants investigated in Maastricht (38) were 0.05% and 0.14%, respectively, in the umbilical artery wall and 0.06% and 0.10%, respectively, in the umbilical vein wall. However, these tissue fatty acid compositional values can presumably be regarded as parameters of exposure to TFAs during longer periods of time than those reflected in plasma lipid values.
We investigated the relation of TFAs to LC-PUFAs in cord vessel wall lipids in a sizable group (n = 308) of Dutch infants (12) . Significant inverse correlations were seen between 18-carbon TFAs and AA and DHA in both artery and vein wall lipids ( Table 3 ). In contrast, we observed not only the lack of inverse correlation but significant positive correlations between trans hexadecenoic acid and AA and DHA. Interestingly, the sum of 18-carbon TFAs was significantly and positively correlated to Mead acid (20:3n-9), a generally accepted indicator of essential fatty acid deficiency, both in artery (r = 0.35, P , 0.01) and vein (r = 0.31, P , 0.01) wall lipids. These findings indicate that fetal exposure to 18-carbon TFAs may be inversely associated with LC-PUFA status at birth.
Little is known about the changes in plasma or erythrocyte membrane lipid TFA values during infancy. TFAs were never a focus of the numerous studies that reported fatty acid compositional data in infants; today ethical considerations also make it difficult to obtain blood samples from healthy infants. We recently compared fatty acid compositional data obtained from erythrocyte membrane lipids in 17 newborns with those from 97 infants investigated at the median age of 6 mo (39). Median TFA values decreased significantly between the 2 periods investigated, from 0.60% to 0.43% in phosphatidylcholine lipids and from 0.66% to 0.30% in phosphatidylethanolamine lipids (39) . The significant decrease in erythrocyte membrane TFA values from birth to the age of 6 mo appears to run in parallel with the significant decrease in TFAs in HM by the age of 6 mo seen in another study (15) . Taken together, these data indicate that the exposure to TFAs is probably the highest around birth, ie, during the most critical period of infant development.
FUNCTIONAL CONSEQUENCES OF EXPOSURE TO TFAS IN THE PERINATAL PERIOD
The potential functional consequences of TFA exposure have been studied both on intrauterine development and pregnancy outcome and on postnatal development and health status.
Association of TFA exposure to pregnancy outcome and fetal development
In one study carried out in the United States, the comparison of dietary TFA intakes in the first-trimester diet of women with undisturbed pregnancies with TFA intakes in women suffering from preeclampsia or gestational diabetes failed to indicate any association of TFA intakes with the prevalence of these obstetrical complications (40) . In another study carried out in Canada, total TFA values in umbilical cord plasma cholesteryl ester lipids were significantly inversely related to the length of gestation but not to birth weight or birth length (8) .
Some studies (24, 27, 28, 38) reported controversial results of significant associations of TFA exposure with intrauterine growth. In 3704 pregnant Dutch women, plasma phospholipid trans octadecenoic acid values were significantly inversely related to birth weight in a univariate model of analysis: a 1-SD increase in the amount of trans octadecenoic acid was associated with a 226-g difference in birth weight (27) . Correspondingly, the risk of delivering a small-for-gestational-age infant increased slightly, but significantly (OR: 1.10; 95% CI: 1.00, 1.21). However, all of the associations between TFAs and intrauterine growth disappeared after adjustment for physiologic, lifestyle-related, and sociodemographic factors (27) .
Controversial results were seen when plasma or erythrocyte membrane phospholipids were analyzed within the same study. No association was reported between plasma phospholipid trans octadecenoic acid values and birth weight, birth length, and head circumference in a sizable cohort (n = 782) of Dutch pregnant women (28) . However, in the same study after full adjustment for confounding factors, a significant inverse association was found between erythrocyte membrane phospholipid trans octadecenoic acid values and birth weight (38) . Very recently, Cohen et al (24) associated TFA consumption with fetal growth in 1369 American women participating in Project Viva. Secondtrimester TFA consumption was significantly positively associated with fetal growth z score (b: 0.29: 95% CI: 0.07, 0.51). Interestingly, the positive association was seen only for trans hexadecenoic acid (16:1n-7t) and one of the trans octadecadienoic acids (18:1n-9tc), but not for trans octadecenoic acid and the other 2 trans octadecadienoic acids (18:2n-6ct and C18:2n-6tt).
On the basis of this contradictory data it is clearly impossible to draw any conclusion on the exact role of TFAs in modifying fetal growth. However, it can be reasonably assumed that TFA exposure may be a previously neglected confounding variable in studies investigating the relation of fetal fatty acid supply to intrauterine growth.
Association of TFA exposure to postnatal development and health outcome
We are aware of 3 studies that investigated the relation of TFA status to postnatal development and health (41) (42) (43) . Wijga et al (42) found a significantly lower prevalence of eczema and asthma at the age of 4 y in children of allergic mothers in whom HM TFA amounts were above the median than in those with HM TFA values under the median. Thijs et al (43) used quartiles of HM fatty acid contents to characterize exposure to TFAs and investigated early development of atopic eczema and allergic sensitization in 310 mother-infant pairs. ORs for parent-reported eczema until the age of 2 y were significantly lower in the highest than in the lowest quartile of HM trans octadecenoic and trans octadecadienoic (18:2n-6ct) acids [OR (95% CI): 0.47 (0.22, 0.97) and 0.48 (0.24, 0.96), respectively]. ORs for atopic dermatitis at the age of 2 y were also lower in the highest quartile of trans octadecadienoic acid (18:2n-6ct), but not in that of trans octadecenoic acid. These data suggest that TFAs of mainly ruminant origin in the diet of mothers might either have protective effects against the development of allergy or might indicate maternal exposure to some other dietary factor protective against allergic sensitization of the offspring.
We used fatty acid compositional data obtained in umbilical blood vessel wall lipids to characterize intrauterine TFA status and investigated neurologic condition of healthy children (n = 290) at 18 mo of age (41) . Children with minimal neurologic dysfunction (n = 15) at 18 mo had significantly higher cord blood vein wall trans octadecadienoic acid (18:2n-6tt) values than neurologically normal children (n = 275). Functionally more importantly, total TFA values as well as total 18-carbon TFA values in umbilical vein wall lipids were significantly inversely associated with the neurologic optimality score, even after adjustment for confounding sociodemographic factors and umbilical vein AA and DHA values (41) . These data indicate that neonates with variables suggestive of high TFA exposure at birth have a less favorable neurologic outcome at 18 mo of age.
The technical aspects of quantifying TFA exposure in the perinatal period as well as methodologic questions of relating exposure data to health outcomes have been already extensively reviewed by an expert committee (20) . In the present article we summarized data obtained mainly during the past decade. We conclude that TFAs still represent a considerable part of the fatty acid composition of HM and may disturb the availability of LC-PUFAs. We believe that the evidence is too weak to recommend dietary guidelines on perinatal TFA intakes. However, the initial data suggesting that TFA exposure might be directly related to some neurologic functions raise further concerns about the nutritional role of TFAs in the perinatal period.
The authors' responsibilities were as follows-TD and GB: equally contributed to the composition of the manuscript. Neither of the authors had any conflicts of interest in connection with the contents of the present article.
